Showing results (631-640 of 646) with videos related to
Sort By:
Pageof 65
Plos One|August 20, 2014
Toxicological profile of ultrapure 2,2',3,4,4',5,5'-heptachlorbiphenyl (PCB 180) in adult ratsMatti Viluksela, Päivi Heikkinen, Leo T M van der Ven, et al.Plants (Basel, Switzerland)|November 27, 2021
Advances in Rootstock Breeding of Nut Trees: Objectives and StrategiesKourosh Vahdati, Saadat Sarikhani, Mohammad Mehdi Arab, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 8, 2021
Umbralisib, a Dual PI3Kδ/CK1ε Inhibitor in Patients With Relapsed or Refractory Indolent LymphomaNathan H Fowler, Felipe Samaniego, Wojciech Jurczak, et al.The New England Journal of Medicine|June 5, 2023
Survival with Axicabtagene Ciloleucel in Large B-Cell LymphomaJason R Westin, Olalekan O Oluwole, Marie José Kersten, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|September 1, 2017
European academy of dermatology and venereology European prurigo project: expert consensus on the definition, classification and terminology of chronic prurigoM P Pereira, S Steinke, C Zeidler, et al.The New England Journal of Medicine|December 10, 2021
Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell LymphomaFrederick L Locke, David B Miklos, Caron A Jacobson, et al.Blood Advances|September 21, 2021
Integrated safety analysis of umbralisib, a dual PI3Kδ/CK1ε inhibitor, in relapsed/refractory lymphoid malignanciesMatthew S Davids, Owen A O'Connor, Wojciech Jurczak, et al.Journal of Photochemistry and Photobiology. B, Biology|February 8, 2018
Annonalide and derivatives: Semisynthesis, cytotoxic activities and studies on interaction of annonalide with DNARicardo A Marques, Akenaton O C V Gomes, Maria V de Brito, et al.The Lancet. Oncology|March 26, 2025
Local anaesthetic transperineal biopsy versus transrectal prostate biopsy in prostate cancer detection (TRANSLATE): a multicentre, randomised, controlled trialRichard J Bryant, Ioana R Marian, Roxanne Williams, et al.Blood|February 12, 2025
Outcomes among adult recipients of CAR T-cell therapy for Burkitt lymphomaLaura Samples, Hossein Sadrzadeh, Matthew J Frigault, et al.Pageof 65